rdf:type |
|
lifeskim:mentions |
umls-concept:C0020823,
umls-concept:C0032854,
umls-concept:C0033325,
umls-concept:C0039512,
umls-concept:C0075804,
umls-concept:C0079083,
umls-concept:C0087111,
umls-concept:C0194037,
umls-concept:C0205214,
umls-concept:C0677886,
umls-concept:C1328050,
umls-concept:C1561558
|
pubmed:issue |
12
|
pubmed:dateCreated |
1996-7-17
|
pubmed:abstractText |
A phase I or II trial was conducted to assess the toxicity and the efficacy of a tandem high dose chemotherapy combining ifosfamide, carboplatin, and teniposide in patients with poor prognosis ovarian carcinoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2550-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8640705-Adult,
pubmed-meshheading:8640705-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8640705-Bone Marrow Transplantation,
pubmed-meshheading:8640705-Carboplatin,
pubmed-meshheading:8640705-Carcinoma,
pubmed-meshheading:8640705-Combined Modality Therapy,
pubmed-meshheading:8640705-Female,
pubmed-meshheading:8640705-Humans,
pubmed-meshheading:8640705-Ifosfamide,
pubmed-meshheading:8640705-Middle Aged,
pubmed-meshheading:8640705-Ovarian Neoplasms,
pubmed-meshheading:8640705-Survival Analysis,
pubmed-meshheading:8640705-Teniposide,
pubmed-meshheading:8640705-Transplantation, Autologous
|
pubmed:year |
1996
|
pubmed:articleTitle |
Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma.
|
pubmed:affiliation |
Department of Medical Oncology, Hospital Tenon, Paris, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|